Dr. John Christopher Oeltjen, MD, PhD

Dr. Oeltjen practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Oeltjen's NPI, 1629099213, was assigned on July 21, 2006. Dr. Oeltjen graduated from Baylor College Of Medicine in 2000. Dr. Oeltjen holds Florida license ME96192.

Dr. Oeltjen's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Oeltjen's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Oeltjen is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Oeltjen to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oeltjen practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Oeltjen's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Oeltjen is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Oeltjen is licensed in Florida.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Oeltjen treats.

CMS data shows 14 Medicare services from Dr. Oeltjen across 1 procedure code in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $776 for them. Every service was in an office.

CMS counts 39 Medicare patients who saw Dr. Oeltjen in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oeltjen's median patient age at 64, with 98% women.

In 2024, Dr. Oeltjen wrote 96 Medicare Part D claims for 26 patients. 99% of them were for generic drugs. CMS names the drug for 68 of them, across 4 drugs with 11 or more claims each, at $319 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Oeltjen for performance year 2024, reported as part of a group. Dr. Oeltjen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Oeltjen, published from 2009 to 2025. The most frequent topics are Molecular Sequence Data, Agammaglobulinaemia Tyrosine Kinase and Base Sequence. Dr. Oeltjen has published most often in Genome Res. Dr. Oeltjen's most frequent co-authors are Zubin J. Panthaki, MD, Wrood M. Kassira, MD and Cristiane Takita, MD.

CMS Open Payments shows 92 general payments to Dr. Oeltjen from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Mentor Worldwide LLC paid the most, $2,417.

Dmand AI lists 1 award for Dr. Oeltjen, most recently CMS Stage 1 EHR in 2013.

Dr. Oeltjen graduated from Baylor College Of Medicine in 2000. Dr. Oeltjen is a member of American Association of Plastic Surgeons, ASPS and American Society of Reconstructive Microsurgeons.

Dr. Oeltjen is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.